Home » Vertex Nearing Goal on Hepatitis C Drug
Vertex Nearing Goal on Hepatitis C Drug
After years of developing what it hopes will be a blockbuster drug to treat the hepatitis C virus, Vertex Pharmaceuticals Inc. of Cambridge is rapidly closing in on its goal: a product that could generate billions of dollars in annual revenue.
boston
boston
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May